Catalysts for $COLL
120 tracked
Apr 17, 2015
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Apr 17, 2015
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Nov 17, 2014
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Nov 17, 2014
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Aug 19, 2014
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Apr 16, 2014
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Mar 12, 2014
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 16, 2014
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jan 16, 2014
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jan 16, 2014
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 12, 2013
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 31, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 31, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Aug 9, 2013
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jul 11, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jul 11, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jul 11, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jul 11, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jul 11, 2013
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
May 15, 2013
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Apr 15, 2013
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 15, 2012
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 27, 2012
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Aug 28, 2012
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jul 9, 2012
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Aug 25, 2011
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Nov 1, 2010
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Nov 1, 2010
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Nov 9, 2009
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Nov 20, 2008
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→